Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06083324
Other study ID # 2023-021-SG
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 3, 2023
Est. completion date May 3, 2024

Study information

Verified date October 2023
Source Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Contact Samantha Campbell
Phone (412) 330-6151
Email samantha.campbell@ahn.org
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 3, 2024
Est. primary completion date February 3, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years to 89 Years
Eligibility Inclusion Criteria: 1. Age 20-89 years 2. Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study. 3. Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI 4. Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel. 5. Individuals not deemed safe to participate in the standard EOC exercise program will be referred to physical therapy or elsewhere Exclusion Criteria: 1. Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Dose esclated resistance training
All individuals will be engaging in resistance training during and/or after their cancer treatment

Locations

Country Name City State
United States AHN CI Exercise Oncology and Resiliency Center Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis Measurement on bioimpedance analysis machine (Inbody 970) 3 months
Primary Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound Measurement via ultrasound and calculation with Jackson-Pollack calculations 3 months
Primary Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen Measurement on bioimpedance analysis machine (Inbody 970) 3 months
Secondary Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen 3 months
Secondary Determine changes in Y-balance score for each leg Y-balance score adds up the distance each leg can move in the front and side directions, divided by the length of the hip. This correlates inversely with fall risk. 3 months
Secondary Determine changes in strength via load measured in pounds from before to after the nutrition and exercise regimen Load is calculated by multiplying sets by repetitions by weight lifted for a specific exercise 3 months
Secondary Determine changes in EQ-5D responses 1-5 and overall score from before to after the nutrition and exercise regimen EQ-5D asks 5 questions rates from 1-5 and an overall rating of health 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients